Document is current
Any future updates will be listed below
-
Authors
Stockfelt, Marit http://orcid.org/0000-0002-4438-4849
Hong, Mun-Gwan
Hesselmar, Bill
Adlerberth, Ingegerd
Wold, Agnes E.
Schwenk, Jochen M.
Lundell, Anna-Carin
Rudin, Anna
-
Funding
Funding for this research was provided by:
Göteborgs Läkaresällskap (779301)
Vetenskapsrådet (2016–01574)
Västra Götalandsregionen (ALFGBG-143331)
Magnus Bergvalls Stiftelse
Göteborgs Universitet
Frimurare Barnhusdirektionen (792731)
-
License Information
Text and Data Mining valid from 2021-03-15
Version of Record valid from 2021-03-15
-
More Information
Article History
Received: 16 December 2020
Accepted: 7 March 2021
First Online: 15 March 2021
Declarations
:
: Parents provided written informed consent for their children and the study was approved by the Ethics Board of Gothenburg (Dnr 363–05 and 674 − 14).
: Not applicable.
: MS, MH, JS, ACL and AR have no conflicts of interest to declare. AEW, IA and BH are shareholders of Flora Innovation, a researcher-driven company that aims to develop preventive therapies against immunoregulatory diseases such as allergy.
